US HB6284 | 2015-2016 | 114th Congress

Status

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on September 28 2016 - 25% progression, died in committee
Action: 2016-09-28 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

EPI Act Eliminate Price Increases Act of 2016 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the manufacturer of a brand name drug from authorizing or commencing the manufacturing, marketing, selling, or distributing of a generic version of the drug from the time the manufacturer is notified by a generic manufacturer that a generic drug application has been submitted until the expiration or forfeiture of the 180-day exclusivity period granted to the generic manufacturer.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

EPI Act Eliminate Price Increases Act of 2016

Sponsors

Rep. Adam Smith [D-WA]

History

DateChamberAction
2016-09-28HouseReferred to the House Committee on Energy and Commerce.
2016-09-28HouseIntroduced in House

Subjects


US Congress State Sources


feedback